Executive Stock Options Based on Ordinary Profit of ¥8.2 Billion
First written in FY2019. 10 of 16 entries say "Advanced", first in FY2020-Q1. Latest entry: FY2027-H1.
0 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「Date of resolution 9 April 2026 Category and number of eligible persons (people) Directors 5 (excluding outside directors) Number of stock acquisition rights (rights)* 159 Class, terms and number of shares underlying the stock acquisition rights (shares)* Common shares 15,900 (Note) 1」
For the resolution dated 9 April 2026, 159 stock acquisition rights covering 15,900 common shares were granted to 5 directors, excluding outside directors. - 2026-05-21AdvancedShare Issuance and Disposal
「The purpose of this plan is to further strengthen the linkage between compensation for directors and the company’s performance and share value, and to enhance their motivation and morale toward sustained improvement in performance and growth in corporate value over the medium to long term by sharing with shareholders not only the benefits of a rising share price but also the risks of a falling share price.」
Regarding stock options with share-based compensation, the company decided on an issuance policy providing for the allocation of up to 460 units to 5 directors. In relation to the existing executive stock option theme, the company continued a scheme designed to link compensation with performance and share value and specified the size of this issuance. - FY2026Disclosure of outstanding stock acquisition rights for fiscal 2025Annual report
「Resolution date 11 April 2025 Category and number of grantees (people) Directors 3 (excluding outside directors) Number of stock acquisition rights (rights) 83 [83] Class, terms and number of shares underlying the stock acquisition rights (shares) Common shares 8,300 [8,300]」
For the resolution dated 11 April 2025, the company disclosed 83 outstanding stock acquisition rights representing 8,300 common shares as of the end of February 2026. - FY2026-H1AdvancedAnnual report
「Resolution date 11 April 2025 Category and number of grantees (people) Directors 3 (excluding outside directors) Number of stock acquisition rights (rights)* 105 Class, terms and number of shares underlying the stock acquisition rights (shares)* Common shares 10,500 (Note) 1」
For the resolution dated 11 April 2025, 105 stock acquisition rights representing 10,500 common shares were granted to 3 directors, excluding outside directors. - FY2025AdvancedAnnual report
「Resolution date 10 April 2024 Category and number of grantees (people) Directors 4 (excluding outside directors) Number of stock acquisition rights (rights)* 167 Class, terms and number of shares underlying the stock acquisition rights (shares)* Common shares 16,700」
The company disclosed that, for the equity-settled stock options resolved on 10 April 2024, 167 stock acquisition rights representing 16,700 common shares were granted to 4 directors. - FY2025-Q1AdvancedAnnual report
「Resolution date 10 April 2024 Category and number of grantees (people) Directors 4 (excluding outside directors) Number of stock acquisition rights (rights)* 237 Class, terms and number of shares underlying the stock acquisition rights (shares)* Common shares 23,700 (Note) 1 Exercise period for the stock acquisition rights* From 31 May 2024 to 30 May 2039」
For the resolution dated 10 April 2024, 237 stock acquisition rights representing 23,700 common shares were granted to 4 directors, excluding outside directors, with a 15-year exercise period. - FY2024ReframedAnnual report
「The payout rate for performance-based compensation is set at 100% of the base amount when the target set at the beginning of the period is achieved, and varies from 0% to 200% based on the performance for the fiscal year and individual evaluations.」
The compensation structure has been reorganized from the previous stock-based compensation grant criteria based on achievement of ordinary profit to a structure in which the payout rate varies from 0% to 200% based on a combination of operating revenue, ordinary profit, progress under the medium-term management plan and individual evaluations. - FY2024-Q1AdvancedAnnual report
「Resolution date 12 April 2023 Category and number of grantees (people) Directors 4 (excluding outside directors) Number of stock acquisition rights (rights)* 257 Class, terms and number of shares underlying the stock acquisition rights (shares)* Common shares 25,700 Exercise period for the stock acquisition rights* From 31 May 2023 to 30 May 2038」
For the resolution dated 12 April 2023, 257 stock acquisition rights representing 25,700 common shares were granted to 4 directors, excluding outside directors, with a 15-year exercise period. - FY2023¥8,501 million against an ordinary profit target of ¥8,800 millionAnnual report
「The ordinary profit target for equity-settled stock options for the fiscal year was ¥8,800 million, while actual ordinary profit was ¥8,501 million.」
For the performance metric for equity-settled stock options, actual ordinary profit was ¥8,501 million against a target of ¥8,800 million. - FY2022Failure to meet the current year's target and increase in the following year's benchmarkAnnual report
「The ordinary profit target for equity-settled stock options for the fiscal year was ¥8,500 million, while actual ordinary profit was ¥6,688 million. Method of calculating the number of grants for the fiscal year ending February 2023: A. If ordinary profit is at least 90% of the publicly disclosed fiscal 2022 figure of ¥8,800 million, 100% of the prescribed number will be granted.」
Ordinary profit related to the current year's equity-settled stock options was ¥6,688 million, against a target of ¥8,500 million. Meanwhile, publicly disclosed ordinary profit was set at ¥8,800 million as the benchmark for the following year. - FY2022-Q1AdvancedAnnual report
「Resolution date 9 April 2021 Category and number of grantees (people) Directors 4 (excluding outside directors) Number of stock acquisition rights (rights)* 400 Class, terms and number of shares underlying the stock acquisition rights (shares)* Common shares 40,000 Exercise period for the stock acquisition rights* From 31 May 2021 to 30 May 2036」
For the resolution dated 9 April 2021, 400 stock acquisition rights representing 40,000 common shares were granted to 4 directors, excluding outside directors, with an exercise period from 31 May 2021 to 30 May 2036. - FY2021AdvancedAnnual report
「The ordinary profit target for equity-settled stock options for the fiscal year was ¥8,500 million, while actual ordinary profit was ¥9,297 million.」
Against the ordinary profit target of ¥8,500 million for the fiscal year's equity-settled stock options, actual ordinary profit was ¥9,297 million. - FY2021-Q1AdvancedAnnual report
「Number of stock acquisition rights (rights)* 377 Class, terms and number of shares underlying the stock acquisition rights (shares)* Common shares 37,700 Exercise period for the stock acquisition rights* From 31 May 2020 to 30 May 2035」
For the resolution dated 10 April 2020, 377 stock acquisition rights representing 37,700 common shares were granted to 3 directors, excluding outside directors. - FY2020ReframedAnnual report
「(Method of calculating the number of grants for the fiscal year ending February 2021) A. If ordinary profit is at least 90% of the publicly disclosed fiscal 2020 figure, 100% of the prescribed number will be granted. B. If ordinary profit is at least 80% but less than 90% of the publicly disclosed fiscal 2020 figure, 50% of the prescribed number will be granted. C. If ordinary profit is at least 70% but less than 80% of the publicly disclosed fiscal 2020 figure, 30% of the prescribed number will be granted. D. If ordinary profit is less than 70% of the publicly disclosed fiscal 2020 figure, none will be granted.」
The performance-based criteria for executive stock options were updated from the fiscal 2019 basis to the fiscal 2020 basis and reset as the method for calculating the following year's grants. - FY2020-Q1AdvancedAnnual report
「Number of stock acquisition rights (rights)* 437 Class, terms and number of shares underlying the stock acquisition rights (shares)* Common shares 43,700 Exercise period for the stock acquisition rights* From 31 May 2019 to 30 May 2034」
For the equity-settled stock options issued on 29 May 2019, 437 stock acquisition rights representing 43,700 common shares were granted to 5 directors, with an exercise period from 31 May 2019 to 30 May 2034. - FY2019First statedAnnual report
「① If ordinary profit is at least 90% of the publicly disclosed fiscal 2019 figure of ¥8,200 million, 100% of the prescribed number will be granted. ② If ordinary profit is at least 80% but less than 90% of the publicly disclosed fiscal 2019 figure of ¥8,200 million, 50% of the prescribed number will be granted. ③ If ordinary profit is at least 70% but less than 80% of the publicly disclosed fiscal 2019 figure of ¥8,200 million, 30% of the prescribed number will be granted. ④ If ordinary profit is less than 70% of the publicly disclosed fiscal 2019 figure of ¥8,200 million, none will be granted.」
The company has disclosed for the first time a mechanism under which the number of equity-settled stock options granted to directors is determined in stages based on the achievement rate against publicly disclosed fiscal 2019 ordinary profit of ¥8,200 million.